LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1987 | 5445 | 0.3659 | 0.2000 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1513 | 5445 | 0.2774 | 0.0419 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4267 | 5905 | 0.7211 | 0.7069 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5118 | 5905 | 0.8669 | 0.8678 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5420 | 5445 | 0.9987 | 0.9994 |
MCF7 | BMS345541 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5438 | 5445 | 1.0020 | 1.0029 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4311 | 5445 | 0.7910 | 0.7744 |
MCF7 | KIN001-043 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5537 | 5445 | 1.0171 | 1.0169 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4859 | 5445 | 0.8951 | 0.8912 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3675 | 5445 | 0.6770 | 0.6408 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6297 | 5905 | 1.0662 | 1.0623 |
MCF7 | YM 201636 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6388 | 5905 | 1.0823 | 1.0775 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5996 | 5905 | 1.0155 | 1.0149 |
MCF7 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1577 | 5445 | 0.2898 | 0.0624 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3786 | 5445 | 0.6951 | 0.6611 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6450 | 5445 | 1.1889 | 1.1853 |
MCF7 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4389 | 5905 | 0.7430 | 0.7344 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4594 | 5445 | 0.8439 | 0.8347 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3839 | 5905 | 0.6494 | 0.6252 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4868 | 5445 | 0.8954 | 0.8915 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5969 | 5905 | 1.0110 | 1.0106 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3737 | 5905 | 0.6332 | 0.6068 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5239 | 5905 | 0.8877 | 0.8892 |
MCF7 | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6419 | 5905 | 1.0870 | 1.0816 |
MCF7 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6120 | 5445 | 1.1282 | 1.1277 |